Cytori Therapeutics, Inc. (CYTX) PT Lowered to $4 at Maxim Group Ahead of Binary Event

February 13, 2018 11:36 AM

Maxim Group lowered its price target on Cytori Therapeutics, Inc. (NASDAQ: CYTX) to $4.00 (from $5.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found